Stevanato Group SpA (STVN)
22.68
-0.02
(-0.09%)
USD |
NYSE |
Aug 26, 14:48
Stevanato Group Total Liabilities (Quarterly) : 1.222B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.222B |
| March 31, 2026 | 1.213B |
| December 31, 2025 | 1.242B |
| September 30, 2025 | 1.148B |
| June 30, 2025 | 1.119B |
| March 31, 2025 | 981.12M |
| December 31, 2024 | 957.25M |
| September 30, 2024 | 995.01M |
| June 30, 2024 | 935.46M |
| March 31, 2024 | 952.90M |
| December 31, 2023 | 1.037B |
| Date | Value |
|---|---|
| September 30, 2023 | 879.04M |
| June 30, 2023 | 823.58M |
| March 31, 2023 | 774.24M |
| December 31, 2022 | 708.43M |
| September 30, 2022 | 651.58M |
| June 30, 2022 | 651.98M |
| March 31, 2022 | 648.61M |
| December 31, 2021 | 656.37M |
| September 30, 2021 | 690.00M |
| June 30, 2021 | 742.31M |
| March 31, 2021 | 752.96M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 5.943B |
| Bio-Rad Laboratories, Inc. | 3.078B |
| Bruker Corp. | 3.617B |
| Danaher Corp. | 39.78B |
| Harvard Bioscience, Inc. | 68.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.994B |
| Shareholders Equity (Quarterly) | 1.772B |
| Debt to Equity Ratio | 0.2858 |
| Current Ratio | 1.613 |
| Net Debt Paydown Yield | -0.33% |